Goldman Sachs raised the firm’s price target on Colgate-Palmolive (CL) to $100 from $98 and keeps a Buy rating on the shares. The firm cites the company’s strong Q1 top and bottom line beat with higher than expected organic sales growth, also noting that broad-based strength flowed through to slightly better than expected gross margins and inline EBIT margins despite ad spending growing 10% in the quarter, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive Expands Strategic Growth and Restructuring Program
- Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
- Morning Movers: Roblox and Western Digital sink after earnings
- Colgate-Palmolive board approves expansion of SGPP
- Options Volatility and Implied Earnings Moves Today, May 01, 2026
